U.S. REITS Stock News

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal expands Twist's antibody discovery services and includes an equity investment and licensing terms that share economics between the two companies. This move adds bispecific antibody capabilities to Twist's existing biologics discovery tools, broadening the range of programs it can support for biotech and pharma customers. Twist...

How D.R. Horton Stock Has Been Performing D.R. Horton (DHI) has seen mixed recent returns, with a small 0.2% decline over the past day and a 1.4% pullback over the past week, alongside a gain over the past month. Over longer periods, the stock shows a 4.6% return over the past 3 months, 12.5% year to date, and 25.6% over the past year, with multi year total returns that are also positive. See our latest analysis for D.R. Horton. At a share price of $163.95, D.R. Horton’s 8.9% 1 month share...

Why Silicon Motion Technology (SIMO) Is Getting Fresh Attention Silicon Motion Technology (SIMO) is back on many watchlists after a period of strong quarterly earnings and revenue growth, combined with technical signals that point to firm price momentum. In addition, analysts have recently lifted their earnings estimates, which many investors read as confirmation that the business performance trends seen in the latest quarter may have some continuity in the near term. See our latest analysis...

What Teradata’s recent returns signal for investors Teradata (TDC) has delivered mixed share price moves, with a roughly 6.8% gain over the past day, a 7.9% decline over the past week, and positive returns over the past month and past 3 months. At a last close of $30.03, the company has a 1 year total return of about 23.6%. Its 3 year and 5 year total returns are both negative, which may catch the eye of investors comparing shorter and longer time frames. See our latest analysis for...

In February 2026, Safehold Inc. reported fourth-quarter and full-year 2025 results showing modest increases in sales, revenue, net income, and earnings per share, and confirmed that no shares were repurchased under the buyback program announced in February 2025. Alongside this, Safehold expanded its ground lease portfolio to 143 assets worth about US$6.50 billion and secured a new US$2.00 billion unsecured revolving credit facility, meaningfully increasing its financial flexibility to...

If you are trying to work out whether Caris Life Sciences at around US$18.20 is a bargain or a value trap, you are in the right place. The stock has been under pressure recently, with a 12.5% decline over the last 7 days, a 27.2% decline over the last 30 days, and a 32.5% decline year to date. Recent attention around Caris Life Sciences has focused on its position in the pharmaceuticals and biotech space and how investors are reassessing risk in the sector. This backdrop helps explain why...

If you are wondering whether Danaos is still good value after its recent run, you are in the right place. This article focuses squarely on what you are paying for each dollar of the business. The stock last closed at US$111.57, with returns of 4.0% over 7 days, 10.8% over 30 days, 17.1% year to date, 41.5% over 1 year and 116.4% over 3 years. These figures naturally raise questions about how much upside or risk is now priced in. Recent coverage of Danaos has highlighted its role in the...

If you are wondering whether Inspire Medical Systems' share price now reflects good value or lingering risk, you are not alone. The stock last closed at US$57.72, with returns of 4.4% decline over 7 days, 27.3% decline over 30 days, 37.4% decline year to date, 68.8% decline over 1 year, 77.8% decline over 3 years and 76.1% decline over 5 years. Recent coverage has focused on how the share price pullback has reshaped expectations around the company and the sleep apnea treatment market it...

Patrick Dumont has been appointed Chief Executive Officer and Chairman of Las Vegas Sands. He succeeds Robert G. Goldstein in both roles, marking a concentrated leadership change at the company. This transition represents a material corporate event for investors in NYSE:LVS. Las Vegas Sands, trading on the NYSE under the ticker LVS, is entering a new phase with Patrick Dumont taking over as both CEO and Chairman. The stock closed at $55.05, with a 1 year return of 26.7% and a relatively...

If you are wondering whether Nicolet Bankshares is still reasonably priced after its strong run, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$156.96, with returns of 11.1% over the last 30 days, 30.3% year to date, and 34.5% over the past year, while the 3 year and 5 year returns sit at 117.7% and 110.4% respectively. These figures may change how you think about risk and reward from here. Recent coverage of...

Earlier today, SentinelOne unveiled a new Singularity Identity portfolio that continuously validates access for both human users and fast-changing AI and non-human identities across endpoints, browsers, and automated workflows. By shifting identity security from one-time authorization to real-time behavioral guardrails, the company is aiming to secure how autonomous agents actually execute work, not just how they log in. We’ll now examine how this push into execution-based identity security...

Trimble stock moves and recent performance snapshot Trimble (TRMB) traded around $66.74 at the last close, with the share price showing small positive moves over the past week, but a weaker patch over the month and the past 3 months. See our latest analysis for Trimble. That recent 2% one day share price gain comes after a softer patch, with a 30 day share price return showing a 6.25% decline and a 90 day share price return showing a 17.88% decline, while the 3 year total shareholder return...

Concentra Group Holdings Parent: Recent Moves In Context With no single headline event driving attention to Concentra Group Holdings Parent (CON), investors are focusing on how its recent share performance and financial profile fit into the occupational health services story. See our latest analysis for Concentra Group Holdings Parent. At a share price of $23.41, Concentra Group Holdings Parent has paired a 1 month share price return of 8.63% with a year to date share price return of 20.61%...

Recent share performance and business snapshot Group 1 Automotive (GPI) has drawn investor attention after a recent share price pullback, with the stock showing a 15% decline over the past month and a 17% decline over the past 3 months. At a last close of $335.07, the company reports annual revenue of $22.57b and net income of $320.0m. It operates a broad network of dealerships and services in the US and UK auto retail market. See our latest analysis for Group 1 Automotive. Looking past the...

Workiva stock performance in focus Workiva (WK) has drawn investor attention after a difficult stretch, with the share price showing negative returns over the month, past 3 months, and year to date, alongside a negative 1 year total return. At a last close of US$57.70 and annual revenue of US$884.57m against a net income loss of US$26.17m, investors are weighing how current pricing aligns with the company’s cloud-based reporting business profile. See our latest analysis for Workiva. For now,...

Omnicom Group (NYSE:OMC) has completed its merger with Interpublic, creating what the company describes as the world's leading marketing and sales group. The combined business is rolling out expanded generative and agentic AI capabilities across its services. Management has announced a major realignment of operations, including divesting non core assets. The board has also authorized a $5b share repurchase program alongside higher synergy targets. For investors watching NYSE:OMC, these...

In February 2026, Neurocrine Biosciences reported that fourth-quarter 2025 revenue rose to US$805.5 million and net income to US$153.7 million, with full-year revenue reaching US$2.86 billion and net income US$478.6 million, alongside higher basic and diluted earnings per share from continuing operations versus 2024. The company also issued 2026 guidance calling for INGREZZA net product sales of US$2.70 billion to US$2.80 billion, underscoring the central role of this flagship therapy in...

If you are wondering whether Corteva at around US$77.97 is offering fair value right now, you are not alone, many investors are asking the same question. The stock has returned 3.2% over the last 7 days, 8.7% over 30 days, 15.1% year to date, 25.1% over 1 year, 29.1% over 3 years and 79.5% over 5 years, which naturally draws attention to what is already priced in. Recent news coverage around Corteva has largely focused on its positioning within the agricultural chemicals space and how...

If you are looking at Energy Transfer and wondering whether the current price reflects its real worth, you are not alone. The stock last closed at US$18.80, with returns of 1.0% over 7 days, 4.5% over 30 days, 13.3% year to date, 7.3% over 1 year and a very large increase over 5 years. Recent headlines around Energy Transfer have focused on the broader midstream energy space and ongoing interest in large pipeline and storage assets. This backdrop helps frame how investors may be thinking...

If you are wondering whether Regal Rexnord’s current share price really reflects what the business is worth, you are not alone. This article is built to help you assess that question clearly. With the stock at US$223.69 and returns of 2.1% over 7 days, 43.3% over 30 days, 53.1% year to date and 69.7% over 1 year, many investors are asking what is already priced in and what might still be on the table in terms of risk and reward. These moves sit against a backdrop where Regal Rexnord...

ATI Inc. (ATI) is back in focus after the board expanded its stock repurchase authorization by US$500 million to a total of US$1.2 billion. This move puts capital returns and long-term growth plans under the spotlight. See our latest analysis for ATI. The buyback expansion lands after a strong run in ATI’s share price, with a 30-day share price return of 30.34% and a 90-day gain of 60.56%, while the 1-year total shareholder return is roughly 7x. This momentum suggests investors are reacting...

Donnelley Financial Solutions recently reported fourth-quarter 2025 results, with revenue rising to US$172.5 million while quarterly net income was essentially flat, confirmed full-year 2025 earnings showing sharply lower net income of US$32.4 million on slightly lower revenue of US$767 million, issued first-quarter 2026 sales guidance of US$200 million to US$210 million, and completed a US$96.19 million share repurchase program covering 7.06% of its shares. This mix of modest quarterly...

Mondelez International has recently reaffirmed its long-term growth targets at the 2026 CAGNY Conference, declared a regular quarterly dividend of US$0.50 per share payable on April 14, 2026, and appointed long-time executive Ziad Abla as Managing Director for Mondelez Arabia to sharpen its focus on the Saudi market. Together, the reaffirmed guidance, ongoing capital returns, and leadership emphasis on Saudi Arabia’s Vision 2030 highlight how Mondelez is aligning its snack portfolio,...

Nebius Group N.V. recently reported full-year 2025 results showing sales rising to US$529.8 million with net income of US$101.7 million, while also announcing an upcoming change of auditor after Reanda Audit & Assurance B.V. completes the 2025 audit and first-quarter 2026 review. At the same time, Nebius is accelerating its AI infrastructure push through major data center expansion, multi‑billion‑dollar hyperscaler contracts, and the Tavily acquisition to strengthen its enterprise AI...